IntelliCell BioSciences, a regenerative medicine company, declared that Millipore has conducted a flow cytometry study of IntelliCell's technology. A division of Merck, Millipore offers advanced technologies, services, and tools for biopharmaceutical manufacturing and bioscience research.
According to the study’s findings, the IntelliCells made using the company’s technology produces about 10 times more SVF cells consisting of adult adipose stem cells from a lesser fat amount.
The flow cytometry study also revealed that IntelliCells obtained from this method comprise all the viable cells produced using the other method, enzymatic digestion.
The autologous adipose stem cells have being extensively used in medicine. Physicians, researchers, and companies are conducting studies to determine the applications that involve the use of adipose stem cells. Some of the areas where adipose stem cells can be used include orthopedic injuries, arthritis treatment, wound healing, back pain, and other diseases.
The autologous adipose stem cells have been widely used in Asia and Europe. The field has undergone rapid expansion since the middle of 2009 when the US FDA announced its laws on autologous stem cells.
IntelliCell has developed a technology to process stromal vascular cells with a highly- viable adipose stem cell concentration. The adipose stem cell processing method takes about half-an-hour and the stem cells can be handed over to the physician the same day.
Source: http://www.intellicellbiosciences.com/